EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Long-term efficacy and safety of canakinumab through 168 weeks in Japanese patients with Schnitzler syndrome: Extended follow-up of the SCan study

Naotomo Kambe, Yoko Amino, Mayuko Yamamoto, Koji Takemura, Shin-Ichiro Kagami, Yoshie Kawahara, Yumiko Ibi, Harue Tada, Satoshi Morita, Nobuo Kanazawa

Allergology International · 2026-11

DOI: 10.1016/j.alit.2026.10.003 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Allergology International, 2026-11. Verfasst von Naotomo Kambe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hyogo Medical University, Nishinomiya, Japan; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyo…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AMED, Government of Japan Ministry of Health Labour and Welfare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, Hyogo Medical University, Nishinomiya, Japan; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: na-kambe@hyo-med.ac.jp.
  • Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Kyoto, Japan.
  • Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan.
  • Research Center for Allergy and Clinical Immunology, Asahi General Hospital, Asahi, Chiba, Japan.
  • Department of Dermatology, Keiyu Hospital, Yokohama, Japan.
  • Department of Dermatology, Hyogo Medical University, Nishinomiya, Japan.

Förderung

  • AMED
  • Government of Japan Ministry of Health Labour and Welfare

Zitieren

APA

Kambe, N., Amino, Y., Yamamoto, M., Takemura, K., Kagami, S. I., Kawahara, Y., Ibi, Y., Tada, H., Morita, S., & Kanazawa, N. (2026). Long-term efficacy and safety of canakinumab through 168 weeks in Japanese patients with Schnitzler syndrome: Extended follow-up of the SCan study. Allergology International. https://doi.org/10.1016/j.alit.2026.10.003

Vancouver

Kambe N, Amino Y, Yamamoto M, Takemura K, Kagami SI, Kawahara Y, et al. Long-term efficacy and safety of canakinumab through 168 weeks in Japanese patients with Schnitzler syndrome: Extended follow-up of the SCan study. Allergology International. 2026. doi:10.1016/j.alit.2026.10.003

BibTeX
@article{Kambe2026,
  author = {Kambe, Naotomo and Amino, Yoko and Yamamoto, Mayuko and Takemura, Koji and Kagami, Shin-Ichiro and Kawahara, Yoshie and Ibi, Yumiko and Tada, Harue and Morita, Satoshi and Kanazawa, Nobuo},
  title = {Long-term efficacy and safety of canakinumab through 168 weeks in Japanese patients with Schnitzler syndrome: Extended follow-up of the SCan study},
  journal = {Allergology International},
  year = {2026},
  doi = {10.1016/j.alit.2026.10.003}
}
Kostenlos starten →